Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis

Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis

Patients with acute myeloid leukemia (AML) and hyperleukocytosis, defined as an initial white blood cell (WBC) count of ≥ 100 × 109/L, are often treated with leukapheresis. In this study, we have reported our experience of treating AML without leukapheresis. Methods: From November 1, 1995, to May 31...

Full description

Bibliographic Details
Main Authors: Kuan-Hao Chen, Hsi-Che Liu, Der-Cherng Liang, Jen-Yin Hou, Ting-Huan Huang, Ching-Yi Chang, Ting-Chi Yeh
Format: Article
Language:English
Published: Elsevier 2014-11-01
Series:Journal of the Formosan Medical Association
Subjects:
acute myeloid leukemia
chemotherapy
children
hyperleukocytosis
leukapheresis
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664614000114

Internet

http://www.sciencedirect.com/science/article/pii/S0929664614000114

Similar Items